Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients

Acta Diabetologica

Volumn 52, Issue 1, 2015, Pages 65-72

  Ziegler, Dan ^a,b   Buchholz, Stefanie ^a   Sohr, Christoph ^a   Nourooz Zadeh, Jaffar ^c   Roden, Michael ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic neuropathy; Heart rate variability; Nerve conduction velocity; Oxidative stress; Superoxide

Indexed keywords

SUPEROXIDE;

ADULT; AGED; AUTONOMIC NERVE; BLOOD; COMPLICATION; DIABETIC NEUROPATHIES; DISEASE COURSE; FEMALE; FOLLOW UP; HEART; HEART RATE; HUMAN; INNERVATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MIDDLE AGED; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PROSPECTIVE STUDY;

ADULT; AGED; AUTONOMIC PATHWAYS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; OXIDATIVE STRESS; PERIPHERAL NERVES; PROSPECTIVE STUDIES; SUPEROXIDES;

EID: 84939600425     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0601-3     Document Type: Article

References (35)

1. Boulton AJM, Vinik AI, Arezzo JC et al (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962
2. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–469
3. Hsu WC, Chiu SY, Yen AM et al (2012) Somatic neuropathy is an independent predictor of all- and diabetes-related mortality in type 2 diabetic patients: a population-based 5-year follow-up study (KCIS No. 29). Eur J Neurol 19:1192–1198
4. Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9:36–45
5. Vincent AM, Callaghan BC, Smith AL, Feldman EL (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 7:573–583
6. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
7. El Boghdady NA, Badr GA (2012) Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct 30:328–334
8. Uzar E, Tamam Y, Evliyaoglu O et al (2012) Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurol Sci 33:875–880
9. Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA (2010) The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 31:261–264
10. Hoeldtke RD, Bryner KD, McNeill DR, Warehime SS, Van Dyke K, Hobbs G (2003) Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab 88:1624–1628
11. Hoeldtke RD, Bryner KD, Hoeldtke ME et al (2006) Sympathetic sudomotor disturbance in early type 1 diabetes mellitus is linked to lipid peroxidation. Metabolism 55:1524–1531
12. Hoeldtke RD, Bryner KD, Corum LL, Hobbs GR, Van Dyke K (2009) Lipid peroxidation in early type 1 diabetes mellitus is unassociated with oxidative damage to DNA. Metabolism 58:731–734
13. Hoeldtke RD, Bryner KD, VanDyke K (2011) Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res 21:19–28
14. Ziegler D, Sohr CGH, Nourooz-Zadeh J (2004) Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and autonomic neuropathy. Diabetes Care 27:2178–2183
15. Ziegler D, Mayer P, Mühlen H, Gries FA (1991) The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34:822–829
16. Dyck PJ, Davies JL, Litchy WJ, O’Brien PC (1997) Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49:229–239
17. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150–154
18. Ziegler D, Laux G, Dannehl K et al (1992) Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 9:166–175
19. Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA (1992) Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 9:806–814
20. Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard EE (1995) Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 667:199–208
21. Nourooz-Zadeh J (1999) Gas chromatography-mass spectrometry assay for measurement of plasma isoprostanes. Methods Enzymol 300:13–17
22. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J et al (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40:647–653
23. Obrosova IG, Minchenko AG, Marinescu V et al (2001) Antioxidants attenuate early upregulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44:1102–1110
24. ® measures the antioxidant capacity of plasma to protect against peroxyl radical attack. In: Stanley PE, Kricka LJ (eds) Bioluminescence chemiluminescence: progress and current applications. World Scientific, London, pp 256–260
25. Low PA, Nickander KK (1991) Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40:873–877
26. Coppey LJ, Gellett JS, Davidson EP, Yorek MA (2003) Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 37:33–40
27. Zherebitskaya E, Akude E, Smith DR, Fernyhough P (2009) Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 58:1356–1364
28. Romero F (1996) Antioxidants in peripheral nerve. Free Radic Biol Med 20:925–932
29. Nickander KK, McPhee BR, Low PA, Tritschler H (1996) Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21:631–639
30. Sayın R, Aslan M, Kucukoglu ME et al (2013) Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Endocrine 2013 Dec 18 [Epub ahead of print]
31. Kasznicki J, Kosmalski M, Sliwinska A et al (2012) Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep 39:8669–8678
32. Acharya JD, Pande AJ, Joshi SM, Yajnik CS, Ghaskadbi SS (2014) Treatment of hyperglycemia in newly diagnosed diabetic patients is associated with a reduction in oxidative stress and improvement in β-cell function. Diabetes Metab Res Rev 2014 Jan 24. doi: 10.1002/dmrr.2526
33. van Dam PS, Bravenboer B, van Asbeck BS, van Oirschot JF, Marx JJ, Gispen WH (1996) Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats. Eur J Clin Invest 26:1143–1149
34. Ziegler D, Low PA, Litchy WJ et al (2011) Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34:2054–2060
35. Pop-Busui R, Stevens MJ, Raffel DM et al (2013) Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia 56:1835–1844